Aytu BioScience (US:AYTU) — Company Overview, News & Financial Data
Aytu BioScience develops novel healthcare products, addressing unmet needs in pediatrics and reproductive health.
Aytu BioScience
Aytu BioScience (NASDAQ:AYTU) is a dynamic healthcare company engaged in developing and commercializing novel products in the fields of pediatrics and reproductive health. Among its innovative offerings are treatments for conditions ranging from sleep disorders to testosterone replacement therapy. The company's mission revolves around addressing unmet or underserved medical needs, aiming to improve patient care with its diversified portfolio. Aytu BioScience is committed to expanding its presence in the healthcare industry through strategic acquisitions, research and development, and collaborations that enhance its product range and market reach.
Snapshot
Operations
Products and/or services of Aytu BioScience
- A treatment for nocturnal polyuria, a condition causing excessive urination during the night.
- Consumer health products, including dietary supplements and wellness products.
- A portfolio of prescription products aimed at addressing conditions in primary care settings.
- A therapeutic for male hypogonadism, a condition characterized by low testosterone levels.
- A product line dedicated to pediatric healthcare, including treatments for certain rare diseases.
- Diagnostic and testing solutions for various medical conditions, including COVID-19 rapid tests.
Aytu BioScience executive team
- Mr. Joshua R. DisbrowCEO & Director
- Mr. Ryan J. Selhorn CPACFO, Corporate Secretary & Treasurer
- Mr. Jarrett T. Disbrow Ph.D.Chief Business Officer
- Mr. Greg PyszczymukaChief Commercial Officer
- Ms. Margaret CabanoVice President of Operations
- Dr. Gerwin Westfield Ph.D.Senior Vice President of Scientific Affairs